BAD-葡萄酶轴调节血小板激活和血栓形成
Mengnan Yang1, Shuang Chen1, Qing Li1
1Jiangsu Institute of Hematology, Cyrus Tang Medical Institute, The First Affiliated Hospital and Collaborative Innovation Center of Hematology, Suzhou Medical College, Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, National Clinical Research Center for Hematological Diseases, Suzhou, China.
Bcl2相关死亡促进体 (BAD) 蛋白质通过与葡萄糖酶相互作用,对血小板激活和动脉血栓形成至关重要. 针对这种BAD-glucokinase轴可能提供新的抗血栓治疗方法.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- Bcl2关联死亡促进体 (BAD) 是一种调节细胞死亡的前性蛋白质.
- BAD在血小板中表达,影响其寿命,亡和清除.
- BAD在血小板激活和动脉血栓形成中的作用尚不清楚.
研究的目的:
- 研究BAD在血小板激活和动脉血栓形成中的作用.
- 阐明BAD影响血小板功能的分子机制.
- 探索BAD-glucokinase途径作为抗血栓性标的潜力.
主要方法:
- 利用了BAD缺乏的小鼠和体外血小板研究.
- 评估了血小板聚合,整合素激活和颗粒分泌.
- 研究了BAD对血小板能量代谢和葡萄糖酶活性的影响.
- 雇佣的葡萄糖酶异合性淘汰小鼠和一个葡萄糖酶激活剂.
主要成果:
- 在小鼠中,BAD缺乏导致长时间出血和动脉封闭时间.
- 缺乏BAD的血小板显示聚合,整合素激活和分泌减少.
- BAD缺乏症降低了血小板血糖激酶活性,线粒体呼吸和ATP的产生.
- 葡萄糖酶缺乏症复制了BAD缺乏症,而葡萄糖酶激活剂挽救了血小板功能.
结论:
- BAD-glucokinase轴对血小板激活和动脉血栓形成至关重要.
- 准BAD-glucokinase通路为抗血栓治疗提供了一个潜在的策略.
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Intracellular Signaling Affects Focal Adhesions
Some...


